Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
- Joerger, Markus
- Wilkins, Justin
- Fagagnini, Stefania
- Baldinger, Reto
- Brenneisen, Rudolf
- Schneider, Ursula
- Goldman, Bea
- Weber, Markus
Publication date
January 2012
DOI Publisher
Bentham Science Publishers Ltd. ISSN
1872-3128Abstract
Cannabinoids exert neuroprotective and symptomatic effects in amyotrophic lateral sclerosis (ALS). We assessed the pharmacokinetics (PK) and tolerability of delta-9-tetrahydrocannabinol (THC) in ALS patients
Add to ORKG